InnoBiopharm was founded in 2016 with aspiration of improving research and development of important new medicine. There are many diseases with patients of unmet medical need still wanting novel medicine for their treatment, including cancer, immune related diseases, and patients with aging related diseases.
ABOUT US
WHAT CAN WE DO?
TISTA
TISTA is a powerful tool to explore next generation breakthrough drugs to change human life. Whether it is for identifying impactful targets, fine-tuning disruptive therapies, or speeding your clinical trials, TISTA is your ultimate solution.
AB VIVA
AB VIVA is InnoBiopharm’s platform for novel selection of antibody hits, antibody leads and antibody candidates. Compared to polyclonal antibodies, our AB VIVA antibodies are human derived, have desirable clinical candidate characteristics, carry better manufacturing criteria, and can be designed to have important clinical features. AB VIVA is geared for your future drug development success.
